Skip to main navigation Skip to search Skip to main content

Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles

  • Hyon Bin Na
  • , Jung Hee Lee
  • , Kwangjin An
  • , Yong Il Park
  • , Mihyun Park
  • , In Su Lee
  • , Do Hyun Nam
  • , Sung Tae Kim
  • , Seung Hoon Kim
  • , Sang Wook Kim
  • , Keun Ho Lim
  • , Ki Soo Kim
  • , Sun Ok Kim
  • , Taeghwan Hyeon
  • Seoul National University
  • Sungkyunkwan University
  • Kyung Hee University
  • Ajou University
  • University of Ulsan
  • Samyang Corporation

Research output: Contribution to journalArticlepeer-review

Abstract

Contrasting images: A new T1 contrast agent for magnetic resonance imaging (MRI) based on MnO nanoparticles reveals a bright signal enhancement and fine anatomic structures in the T1-weighted MR image of a mouse brain (see picture; left MRI, right MnO-enhanced MRI (MONEMRI)). Furthermore, MnO nanoparticles conjugated with a tumor-specific antibody were used for selectively imaging breast cancer cells in a metastatic tumor in brain. (Figure Presented).

Original languageEnglish
Pages (from-to)5397-5401
Number of pages5
JournalAngewandte Chemie - International Edition
Volume46
Issue number28
DOIs
StatePublished - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Contrast agents
  • Imaging agents
  • Magnetic resonance imaging
  • Manganese
  • Nanoparticles

Fingerprint

Dive into the research topics of 'Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles'. Together they form a unique fingerprint.

Cite this